Stay updated with breaking news from Bartonf Haynes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at the Duke Human Vaccine Institute undergo the first ever breakthrough in developing a broadly neutralising vaccine that may be the hope for AIDS treatment in the near future. TheHealthSite.com
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
A trial on humans for HIV vaccine shows it triggers neutralizing antibodies in the body leading to a promising future for a vaccine.
An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.
A vaccine designed to protect against three different deadly coronaviruses shows success in mouse studies, demonstrating the viability of a pan-coronavirus vaccine developed by researchers at the Duke Human Vaccine Institute.